Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Go back to Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities| (NASDAQ: PSNL) | Delayed: 16.02 +0.14 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.88 | 52 Week High | $ | |||
| Open | $15.86 | 52 Week Low | $ | |||
| Day High | $16.13 | P/E | N/A | |||
| Day Low | $15.80 | EPS | $ | |||
| Volume | 370,237 | |||||



